Professor James Jarrett
- Honorary Senior Research Fellow (School of Biodiversity, One Health & Veterinary Medicine)
Publications
2002
Dunham, S.P. et al. (2002) Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and-18. Vaccine, 20, pp. 1483-1496. (doi: 10.1016/S0264-410X(01)00507-2)
Hosie, M.J. ORCID: https://orcid.org/0000-0002-4313-5023, Willett, B.J.
ORCID: https://orcid.org/0000-0001-8912-3266, Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., Neil, J.C.
ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(2002)
Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.
Journal of Virology, 76(12),
pp. 6062-6072.
(doi: 10.1128/JVI.76.12.6062-6072.2002)
2000
Hosie, M.J. et al. (2000) Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. Journal of Virology, 74(20), pp. 9403-9411. (doi: 10.1128/JVI.74.20.9403-9411.2000)
Flynn, J.N., Hosie, M.J. ORCID: https://orcid.org/0000-0002-4313-5023, Rigby, M.A., Mackay, N., Cannon, C.A., Dunsford, T., Neil, J.C.
ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(2000)
Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination.
Vaccine, 18(11-12),
pp. 1118-1132.
(doi: 10.1016/S0264-410X(99)00375-8)
(PMID:10590334)
1999
Flynn, J.N., Cannon, C.A., Sloan, D., Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1999)
Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes.
Immunology, 96(2),
pp. 220-229.
(PMID:10233699)
(PMCID:PMC2326736)
1998
Hosie, M.J. et al. (1998) DNA vaccination affords significant protection against feline immunodeficiency virus without inducing detectable antiviral antibodies. Journal of Virology, 72(9), pp. 7310-7319.
Ramsey, I.K. ORCID: https://orcid.org/0000-0002-7379-9488, Spibey, N. and Jarrett, O.
(1998)
The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization.
Journal of Virology, 72(4),
(PMID:9525654)
(PMCID:PMC109800)
Beatty, J.A., Lawrence, C.E., Callanan, J.J, Grant, C.K, Gault, E.A, Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1998)
Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis.
Veterinary Immunology and Immunopathology, 65(2-4),
pp. 309-322.
(doi: 10.1016/S0165-2427(98)00164-0)
(PMID:9839882)
1997
Flynn, J.N., Cannon, C.A., Neil, J.C. and Jarrett, O. (1997) Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection. Journal of Virology, 71(10), pp. 7586-7592. (PMCID:PMC192106)
Rigby, M.A., Hosie, M.J., Willett, B.J., Mackay, N., McDonald, M., Cannon, C., Dunsford, T., Jarrett, O. and Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279
(1997)
Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation.
AIDS Research and Human Retroviruses, 13(5),
pp. 405-12.
(doi: 10.1089/aid.1997.13.405)
(PMID:9075482)
1996
Flynn, J.N., Keating, P., Hosie, M.J. ORCID: https://orcid.org/0000-0002-4313-5023, Mackett, M., Stephens, E.B., Beatty, J.A., Neil, J.C.
ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1996)
Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
Journal of Immunology, 157(8),
pp. 3658-65.
(PMID:8871667)
Rigby, M.A., Mackay, N., Reid, G., Osborne, R., Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1996)
Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein.
Vaccine, 14(12),
pp. 1095-1102.
(doi: 10.1016/0264-410X(96)00060-6)
(PMID:8911003)
Articles
Dunham, S.P. et al. (2002) Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and-18. Vaccine, 20, pp. 1483-1496. (doi: 10.1016/S0264-410X(01)00507-2)
Hosie, M.J. ORCID: https://orcid.org/0000-0002-4313-5023, Willett, B.J.
ORCID: https://orcid.org/0000-0001-8912-3266, Klein, D., Dunsford, T.H., Cannon, C., Shimojima, M., Neil, J.C.
ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(2002)
Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence.
Journal of Virology, 76(12),
pp. 6062-6072.
(doi: 10.1128/JVI.76.12.6062-6072.2002)
Hosie, M.J. et al. (2000) Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus. Journal of Virology, 74(20), pp. 9403-9411. (doi: 10.1128/JVI.74.20.9403-9411.2000)
Flynn, J.N., Hosie, M.J. ORCID: https://orcid.org/0000-0002-4313-5023, Rigby, M.A., Mackay, N., Cannon, C.A., Dunsford, T., Neil, J.C.
ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(2000)
Factors influencing cellular immune responses to feline immunodeficiency virus induced by DNA vaccination.
Vaccine, 18(11-12),
pp. 1118-1132.
(doi: 10.1016/S0264-410X(99)00375-8)
(PMID:10590334)
Flynn, J.N., Cannon, C.A., Sloan, D., Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1999)
Suppression of feline immunodeficiency virus replication in vitro by a soluble factor secreted by CD8+ T lymphocytes.
Immunology, 96(2),
pp. 220-229.
(PMID:10233699)
(PMCID:PMC2326736)
Hosie, M.J. et al. (1998) DNA vaccination affords significant protection against feline immunodeficiency virus without inducing detectable antiviral antibodies. Journal of Virology, 72(9), pp. 7310-7319.
Ramsey, I.K. ORCID: https://orcid.org/0000-0002-7379-9488, Spibey, N. and Jarrett, O.
(1998)
The receptor binding site of feline leukemia virus surface glycoprotein is distinct from the site involved in virus neutralization.
Journal of Virology, 72(4),
(PMID:9525654)
(PMCID:PMC109800)
Beatty, J.A., Lawrence, C.E., Callanan, J.J, Grant, C.K, Gault, E.A, Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1998)
Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis.
Veterinary Immunology and Immunopathology, 65(2-4),
pp. 309-322.
(doi: 10.1016/S0165-2427(98)00164-0)
(PMID:9839882)
Flynn, J.N., Cannon, C.A., Neil, J.C. and Jarrett, O. (1997) Vaccination with a feline immunodeficiency virus multiepitopic peptide induces cell-mediated and humoral immune responses in cats, but does not confer protection. Journal of Virology, 71(10), pp. 7586-7592. (PMCID:PMC192106)
Rigby, M.A., Hosie, M.J., Willett, B.J., Mackay, N., McDonald, M., Cannon, C., Dunsford, T., Jarrett, O. and Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279
(1997)
Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation.
AIDS Research and Human Retroviruses, 13(5),
pp. 405-12.
(doi: 10.1089/aid.1997.13.405)
(PMID:9075482)
Flynn, J.N., Keating, P., Hosie, M.J. ORCID: https://orcid.org/0000-0002-4313-5023, Mackett, M., Stephens, E.B., Beatty, J.A., Neil, J.C.
ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1996)
Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
Journal of Immunology, 157(8),
pp. 3658-65.
(PMID:8871667)
Rigby, M.A., Mackay, N., Reid, G., Osborne, R., Neil, J.C. ORCID: https://orcid.org/0000-0003-4447-8279 and Jarrett, O.
(1996)
Immunogenicity of a peptide from a major neutralising determinant of the feline immunodeficiency virus surface glycoprotein.
Vaccine, 14(12),
pp. 1095-1102.
(doi: 10.1016/0264-410X(96)00060-6)
(PMID:8911003)